India remains a leading supplier of affordable medicines to the United States, providing nearly half of its generic drug requirements. With pharmaceutical exports worth $27.9 billion in FY24, a third of which went to the US, experts stress that the country’s role in stabilising global healthcare through generics is firmly established.